<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F11E21C9-E05F-4173-939C-61F868FE1FBA"><gtr:id>F11E21C9-E05F-4173-939C-61F868FE1FBA</gtr:id><gtr:name>The Wellcome Trust Ltd</gtr:name><gtr:address><gtr:line1>215 Euston Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>NW1 2BE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F11E21C9-E05F-4173-939C-61F868FE1FBA"><gtr:id>F11E21C9-E05F-4173-939C-61F868FE1FBA</gtr:id><gtr:name>The Wellcome Trust Ltd</gtr:name><gtr:address><gtr:line1>215 Euston Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>NW1 2BE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6F3C80C5-1E93-4E7B-A050-C6C768F1632C"><gtr:id>6F3C80C5-1E93-4E7B-A050-C6C768F1632C</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Festenstein</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C5D3D1A9-04B5-40FB-B91F-18DF7BB6FB29"><gtr:id>C5D3D1A9-04B5-40FB-B91F-18DF7BB6FB29</gtr:id><gtr:firstName>Luis</gtr:firstName><gtr:surname>Arag?n</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9B303E4A-D3C9-4FA3-9B90-9A6A8ADD48DB"><gtr:id>9B303E4A-D3C9-4FA3-9B90-9A6A8ADD48DB</gtr:id><gtr:firstName>Robin</gtr:firstName><gtr:surname>Allshire</gtr:surname><gtr:orcidId>0000-0002-8005-3625</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0301153"><gtr:id>CA5C33BF-7495-4FA3-9C6D-162972434997</gtr:id><gtr:title>Deciphering the epigenetic code</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0301153</gtr:grantReference><gtr:abstractText>As every cell of our bodies contains every gene it follows that for cells to perform different functions some genes much be switched off and others switched on in a given cell type. These studies will examine how cells remember to keep some genes on and others off. We will do this by examining the way genes are packaged and labelled as on or off by directly looking at the packaging surrounding active and inactive genes. When these mechanisms go wrong this can lead to diseases, by understanding this process we hope to work out better ways to treat such diseases in the future.</gtr:abstractText><gtr:technicalSummary>Histone tails protruding from the nucleosome are modified at selected amino acids, by e.g. lysine acetylation, lysine and arginine methylation, serine phosphorylation and attachment of ubiquitin, generating an epigenetic code thought to be essential for cells to establish and ?remember? specific programmes of gene expression during cellular differentiation.

Recently new insights have been gained into how single histone modifications affect chromatin function. However, to fully decipher the information capacity of histone tails, a better understanding is essential of how specific combinations of tail modifications are generated and how the modification of one residue can affect that of another. 

The main tools presently used to study the epigenetic code are antibodies against specific histone modifications. Unfortunately, such approaches miss the potential effect of various combinations of histone modifications. Furthermore, it has been proven to be extremely difficult to generate antisera even to single histone modifications with a high enough selectivity, to distinguish between similar modifications on different residues or different modifications on the same residue, for example di-versus trimethylated histones.

It is now apparent that the application of high-resolution mass spectometry approaches should allow the unambiguous identification of histone modifications associated with particular chromatin fractions. Such techniques require specialist expertise which we will obtain by collaboration with Axel Imhof (University of Munich) allowing the establishment of this methodology for our use (and the use of others). Such methodology will negate the use of specific antisera or at least make their use less critical. Moreover, we also use mass spectrometry to better define the specificity of antibodies directed against histone modifications.

Genetic studies of the archetypal epigenetic phenomenon of position-effect variegation (PEV) have proved invaluable for identifying key components and modifiers of chromatin structure. In PEV, a gene located abnormally close to heterochromatin is stochastically silenced in a proportion of cells in which it is normally expressed. The extent of silencing in PEV is dependent on histone-modifying enzymes and proteins that bind to the specific sites created by these enzymes. In three model organisms (yeast, Drosophila and mice), we will determine the modifications associated with silent chromatin. Subsequently, the histone-tail residues carrying these modifications will then be altered by targeted mutagenesis (in yeast) to directly test the role of particular histone tail (H3 and H4) amino acids in the establishment of gene silencing/activation and centromere function.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>938762</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Cell Biology</gtr:department><gtr:description>RA</gtr:description><gtr:id>6B48960D-3903-4EB6-98E6-15F6214CF9B7</gtr:id><gtr:impact>Identification of a function for histone H3 K4 in regulating gene silencing.</gtr:impact><gtr:partnerContribution>They have provided in-depth knowledge, training and reagents as well as directly contributing to the research project as co-investigator</gtr:partnerContribution><gtr:piContribution>PI on cross-disciplinary project to identify and characterise the role of histone modifications in gene regulation in eukaryotes.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Adolf Butenandt Institute</gtr:department><gtr:description>AI</gtr:description><gtr:id>AD2ADEDE-2EA7-424F-87A8-59CAE3B84CF7</gtr:id><gtr:impact>Identification of a novel histone modification</gtr:impact><gtr:partnerContribution>Identification of a novel histone modification</gtr:partnerContribution><gtr:piContribution>Mass spectometry</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>KE</gtr:description><gtr:id>99CB1EF3-1B2B-43B5-85C0-87B32C1E81A7</gtr:id><gtr:impact>Fundamental key information on the function of a novel histone modification in euakryotes</gtr:impact><gtr:partnerContribution>Epigenomic mapping by microarray using chromatin immunorprecipitation</gtr:partnerContribution><gtr:piContribution>We discovered a novel histone modification, investigated its function and provided the antibody to enable chromatin immunoprecipitation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Sciences Centre</gtr:department><gtr:description>LA</gtr:description><gtr:id>C6B049A8-3351-4953-A144-ACB3505CA36F</gtr:id><gtr:impact>Discovery and characterisation genome-wide of a novel histone modification central to transcriptional regulation.</gtr:impact><gtr:partnerContribution>Expertise in yeast genetics</gtr:partnerContribution><gtr:piContribution>Initiated and established group working on histone modifications from yeast to mammals</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>TV documentary</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CE860E57-FBBE-486C-B565-8384205895ED</gtr:id><gtr:impact>Interviewed for EU funded TV documentarty on Epigenetics

Communicated key ideas to a large lay audience</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TV-interview Dublin</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>54E0874F-900F-4540-870A-BAC551EC329E</gtr:id><gtr:impact>Interviewed at International conference for Friedreich's Ataxia

Raised the profile of the need for research in triplet-repeat diseases</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Post Doctoral Fellowship</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>3E645025-D339-4CB3-B9E6-6AD952550C60</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Epigenome bioinformatics tool to visualise gene expression profiles simulataneously with genome-wide data provided by chromatin immunoprecipitation.</gtr:description><gtr:id>BFC23840-8C24-4E61-BE89-262284DE19DA</gtr:id><gtr:impact>Has allowed rapid identification an interrogation of regions of the genome responding to epigenetic modifiers</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>TROY</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Polyclonal antibody specific to histone H3 lysine 4 acetylation</gtr:description><gtr:id>B85464CE-E038-4FC3-8D67-329E0D7BDD98</gtr:id><gtr:impact>Identification that histone H3 is modified on a key residue, lysine 4, in yeast and mammals. This changes our understanding of how gene's are regulated in eukaryotes as indicated by our genome-wide epigenomic and functional studies.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Identification of histone H3 K4acetylation as a novel post-translational modification using a novel antibody</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Established a murine model to enable chromatin immunoprecipitation and purification of protein complexes using a biotin-tagged version of heterochromatin-protein 1 expressed in vivo.</gtr:description><gtr:id>8D363875-3BB5-4325-A269-57791DAB8020</gtr:id><gtr:impact>Will enable epigenomic maps to be established for this protein using ex vivo tissue circumventing technical problems the field has faced related to use of antibodies for this purpose.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>HP1beta-bio</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Murine model to explore function of key chromatin component.</gtr:description><gtr:id>69398741-47BD-4955-8C9D-D9E2FCE128EF</gtr:id><gtr:impact>Established that this modifier is a potential modifier of heterochromatin-mediated silencing and triplet-repeat diseases.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>HP1gamma transgenics</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/75F40B75-D618-4BAC-87CA-2E4175798666"><gtr:id>75F40B75-D618-4BAC-87CA-2E4175798666</gtr:id><gtr:title>Fission yeast Scm3: A CENP-A receptor required for integrity of subkinetochore chromatin.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d9e52699f99a53969675b69c1492e501"><gtr:id>d9e52699f99a53969675b69c1492e501</gtr:id><gtr:otherNames>Pidoux AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7D17D931-7671-4ACB-B065-2A3084BB7308"><gtr:id>7D17D931-7671-4ACB-B065-2A3084BB7308</gtr:id><gtr:title>Analysis of small RNA in fission yeast; centromeric siRNAs are potentially generated through a structured RNA.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/46858a9bdd07bdbf29c21ad35280c1e5"><gtr:id>46858a9bdd07bdbf29c21ad35280c1e5</gtr:id><gtr:otherNames>Djupedal I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D3B7FE3C-08B4-4BF9-A5F7-1FD155B9B66C"><gtr:id>D3B7FE3C-08B4-4BF9-A5F7-1FD155B9B66C</gtr:id><gtr:title>Splicing factors facilitate RNAi-directed silencing in fission yeast.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6bf9093a0530c39a761e7f7c70c736fb"><gtr:id>6bf9093a0530c39a761e7f7c70c736fb</gtr:id><gtr:otherNames>Bayne EH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B3ECD837-0A8A-418C-BA11-5572561D9376"><gtr:id>B3ECD837-0A8A-418C-BA11-5572561D9376</gtr:id><gtr:title>Silencing mediated by the Schizosaccharomyces pombe HIRA complex is dependent upon the Hpc2-like protein, Hip4.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/984e460e0199e59dcac57ab8d94077de"><gtr:id>984e460e0199e59dcac57ab8d94077de</gtr:id><gtr:otherNames>Anderson HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/069B482F-CDA6-4B0D-AA22-3E6543150496"><gtr:id>069B482F-CDA6-4B0D-AA22-3E6543150496</gtr:id><gtr:title>H3 lysine 4 is acetylated at active gene promoters and is regulated by H3 lysine 4 methylation.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1d489acdd72e8dc0a1791df6383a55df"><gtr:id>1d489acdd72e8dc0a1791df6383a55df</gtr:id><gtr:otherNames>Guillemette B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0A4E73AF-65CB-4ED1-AA52-4DB791B04053"><gtr:id>0A4E73AF-65CB-4ED1-AA52-4DB791B04053</gtr:id><gtr:title>Synthetic heterochromatin bypasses RNAi and centromeric repeats to establish functional centromeres.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1c85a822f817ca8ea4d576998fa40761"><gtr:id>1c85a822f817ca8ea4d576998fa40761</gtr:id><gtr:otherNames>Kagansky A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A73046B7-F007-462D-805F-B99B537767F8"><gtr:id>A73046B7-F007-462D-805F-B99B537767F8</gtr:id><gtr:title>Stc1: a critical link between RNAi and chromatin modification required for heterochromatin integrity.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6bf9093a0530c39a761e7f7c70c736fb"><gtr:id>6bf9093a0530c39a761e7f7c70c736fb</gtr:id><gtr:otherNames>Bayne EH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0301153</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>